CATTLYST- laidlomycin propionate potassium granule

Cattlyst by

Drug Labeling and Warnings

Cattlyst by is a Animal medication manufactured, distributed, or labeled by Phibro Animal Health. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Cattlyst 50G

Laidlomycin propionate potassium

Type A Medicated Article

Net Wt 50 LB (22.68 kg)

SPL UNCLASSIFIED SECTION

For further manufacturing only.

Active Drug Ingredient

Laidlomycin propionate potassium, 50 grams per pound, in a carrier suitable for incorporation in feed.

Weight Gain and Feed Efficiency

For increased rate of weight gain and improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter when fed a complete Type C medicated feed containing 5 g/ton laidlomycin propionate potassium to provide 30 to 75 mg laidlomycin propionate potassium per head per day.

For improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter when fed a complete Type C medicated feed containing 5 to 10 g/ton laidlomycin propionate potassium to provide 30 to 150 mg laidlomycin propionate potassium per head per day.

Not for use in animals intended for breeding.

Mixing And Feeding Instructions

Read all directions carefully before mixing and feeding.

Type B Medicated Feed

Thoroughly mix the following amounts of Cattlyst 50G to make one ton of Type B medicated feed containing the concentrations laidlomycin propionate potassium shown in TABLE 1. When using small quantities of Cattlyst 50G (e.g. two lb/ton or less), perform an intermediate blending step to ensure adequate mixing.

Type B liquid medicated feed manufactured from Cattlyst 50G must have a dry matter content between 62 and 75%, pH between 6.0 to 8.0, and concentration of laidlomycin propionate potassium of 100 to 2,000 g/ton. The label of the Type B liquid medicated feed must carry daily, and prior to use, recirculating/agitation directions and an expiration of 21 days from date of manufacture. The Type C medicated feed manufactured from this Type B liquid medicated feed must be fed within 7 days from date of manufacture.

TABLE 1 - Type B Medicated Feed

Pounds of Cattlyst 50G per ton of Type B medicated feed	Laidlomycin propionate potassium concentration in Type B medicated feed (g/ton)
2	100
4	200
20	1,000
40	2,000

Type C Medicated Feed

Thoroughly mix the following amounts of Cattlyst 50G to make one ton of Type C Medicated Feed that provides 5-10 grams of laidlomycin propionate potassium per ton of feed on a 90% dry matter basis (TABLE 2). An intermediate blending step should be performed to ensure adequate mixing. For example, use one part Cattlyst 50G Type A Medicated Article with nine parts of feed ingredients to prepare an intermediate blend before preparing a Type C Medicated Feed.

TABLE 2 - Type C Medicated Feed

Pounds of Cattlyst 50G per ton of complete Type C medicated feed	Pounds of a 1,000 g/ton Type B medicated feed per ton of complete Type C medicated feed	Laidlomycin propionate potassium concentration in complete Type C medicated feed (g/ton)
0.1	10	5
0.15	15	7.5
0.20	20	10

Feeding Directions

Feed the Type C medicated feed as the sole ration.

Animal Safety Warning

Do not allow horses or other equines access to feeds containing laidlomycin propionate potassium (Cattlyst 50G). The safety of laidlomycin propionate potassium (Cattlyst 50G) in unapproved species has not been established.

User Safety Warnings

When mixing and handling Cattlyst 50G use appropriate protective clothing, eye, face, and respiratory protection. If accidental eye or skin contact occurs, rinse immediately with water. Operators should wash thoroughly with soap and water after handling Cattlyst 50G.

Keep container closed between uses.

Store below 25°C (77°F), excursions permitted to 37°C (99°F).

Restricted Drug (California) - Use Only as Directed. Not for human use.

WITHDRAWAL PERIODS

No withdrawal period is required when used according to labeling.

Approved by FDA under NADA # 141-025 Questions/Comments? For technical assistance or to obtain a Safety Data Sheet(s), contact Phibro Animal Health Corporation at 888-403-0074 or www.pahc.com. To report side effects, contact Phibro Animal Health Corporation at 1-888-475-7355. For additional information about reporting side effects, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae Phibro, Phibro logo and Cattlyst are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates.

SPL UNCLASSIFIED SECTION

Distributed by:
Phibro Animal Health Corporation
Teaneck, NJ 07666

Net Wt 50 LB (22.68 kg)

176-9014-03

Cattlyst 50 Label

Label

INGREDIENTS AND APPEARANCE

CATTLYST 
laidlomycin propionate potassium granule

Product Information
Product Type	OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG	Item Code (Source)	NDC: 66104-2000
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LAIDLOMYCIN PROPIONATE POTASSIUM (UNII: 05TAA9I0Z8) (LAIDLOMYCIN - UNII:MI3S6ZF5QE)	LAIDLOMYCIN	50 g  in 0.45 kg

Product Characteristics
Color	white (white to off white)	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 66104-2000-1	22.68 kg in 1 BAG

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NADA	NADA141025	01/01/2009

Labeler - Phibro Animal Health (006989008)